Physician profile
Paul Nager
NPI 1821047440
$10,004.08
in general payments reported to CMS, 2019-2025
41 companies · $1,009 in 2025
The $1,009 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,358 · 2020: $822 · 2021: $1,094 · 2022: $1,209 · 2023: $1,271 · 2024: $1,242 · 2025: $1,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,521.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,382.26 | 2019-2022 | |
| Amgen INC. | $1,125.26 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $1,021.33 | 2019-2025 | Watchman Flx, Emblem Mri S-Icd, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $500.57 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $500.46 | 2019-2025 | |
| Astellas Pharma US INC | $440.10 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $436.94 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $427.81 | 2019-2025 | Lifevest |
| Medtronic, INC. | $311.11 | 2021-2025 | Linq II, Affera Mapping System, Micra |
| Irhythm Technologies, INC. | $304.38 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Shockwave Medical, INC | $285.03 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $232.19 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $202.78 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $186.40 | 2019-2023 | |
| Livanova USA, INC. | $152.02 | 2019 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Nager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.